MacroGenics
MGNX
#9411
Rank
HK$1.02 B
Marketcap
HK$16.07
Share price
3.54%
Change (1 day)
45.34%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -HK$4.49

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -HK$4.47. In 2025 the company made an earnings per share (EPS) of -HK$9.25 a decrease over its 2024 EPS that were of -HK$8.39.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$4.49-51.48%
2025-HK$9.2510.28%
2024-HK$8.39613.33%
2023-HK$1.18-92.31%
2022-HK$15.29-42.14%
2021-HK$26.4236.44%
2020-HK$19.36-21.84%
2019-HK$24.77-24.58%
2018-HK$32.85675.93%
2017-HK$4.23-68.05%
2016-HK$13.25168.25%
2015-HK$4.94-55%
2014-HK$10.973400%
2013-HK$0.31-108.68%
2012HK$3.6124.49%
2011HK$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.15-5,519.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.24-3,149.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.30 443.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.43-892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-HK$12.31 175.44%๐Ÿ‡บ๐Ÿ‡ธ USA